Cargando…
Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer”
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Clinical Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477930/ https://www.ncbi.nlm.nih.gov/pubmed/27480154 http://dx.doi.org/10.1200/JCO.2016.68.8010 |
_version_ | 1783244870440189952 |
---|---|
author | Daly, Louise E. Ryan, Aoife M. Power, Derek G. |
author_facet | Daly, Louise E. Ryan, Aoife M. Power, Derek G. |
author_sort | Daly, Louise E. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5477930 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | American Society of Clinical Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-54779302017-06-29 Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” Daly, Louise E. Ryan, Aoife M. Power, Derek G. J Clin Oncol Correspondence American Society of Clinical Oncology 2016-11-01 2016-08-01 /pmc/articles/PMC5477930/ /pubmed/27480154 http://dx.doi.org/10.1200/JCO.2016.68.8010 Text en © 2016 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License: http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Correspondence Daly, Louise E. Ryan, Aoife M. Power, Derek G. Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” |
title | Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” |
title_full | Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” |
title_fullStr | Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” |
title_full_unstemmed | Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” |
title_short | Response to “Loss of Muscle Mass During Chemotherapy Is Predictive for Poor Survival of Patients With Metastatic Colorectal Cancer” |
title_sort | response to “loss of muscle mass during chemotherapy is predictive for poor survival of patients with metastatic colorectal cancer” |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477930/ https://www.ncbi.nlm.nih.gov/pubmed/27480154 http://dx.doi.org/10.1200/JCO.2016.68.8010 |
work_keys_str_mv | AT dalylouisee responsetolossofmusclemassduringchemotherapyispredictiveforpoorsurvivalofpatientswithmetastaticcolorectalcancer AT ryanaoifem responsetolossofmusclemassduringchemotherapyispredictiveforpoorsurvivalofpatientswithmetastaticcolorectalcancer AT powerderekg responsetolossofmusclemassduringchemotherapyispredictiveforpoorsurvivalofpatientswithmetastaticcolorectalcancer |